By David Tuller, DrPH I spent the last week of November in Oslo. The Norwegian ME Association invited me to give a couple of talks and have some meetings with public health officials. The city was charming, even if dark and overcast at this time of year. Not surprisingly, the ...

By David Tuller, DrPH Yet another interesting development has taken place at Cochrane, and this new development again suggests that things there might be moving in the right direction. On Friday, the organization withdrew a protocol for what is called an individual patient data (or IPD) review of exercise therapy ...

By David Tuller, DrPH Earlier today, I sent the following e-mail to Dr Fiona Godlee, editorial director of BMJ. I cc'd Carol Monaghan MP, Darren Jones MP, and Nicky Morgan MP. I also cc'd Teresa Allen of the Health Research Authority. ********** Dear Dr. Godlee, As you know, I have ...

By David Tuller, DrPH In what can only be characterized as a welcome surprise, Cochrane has rejected the revision of a 2014 review of exercise treatments for chronic fatigue syndrome, stating that the work does not meet the organization’s quality standards. Cochrane revealed the decision late Friday in a statement ...

By David Tuller, DrPH The UK's National Institute for Health and Care Excellence (NICE), which develops clinical guidelines for a range of medical conditions, is currently selecting a committee to develop a new guidance for the illness it refers to as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The new guidance will ...